ERCC1 and non-small cell lung carcinoma: Interestingly, a study in patients with non-small-cell lung cancer on a docetaxel/cisplatin regimen showed the opposite association, that is, longer survival of the patients with T/T genotypes by the ERCC1 Asn118Asn polymorphism compared to patients with C/T and C/C genotypes (24).